Cel Sci Corporation (CVM)

[sunpillar]

I hear a lot of chatter (and expectations) about the IDMC meeting in September. That said, I cannot find any real proof, that this is the case.

Or, put another way, is this really more of an assumption/hope, based solely on past meeting patterns?


From what I have read (IDMC's own regulations), it seems the committee meets four times a year when the trial is actively recruiting/treating patients (every 3 months).

However, no patients are actually being treated at this point, so do they meet less frequently? (They are simply monitoring "events").


Also, the "September 2019" trial end date on the FDA site, wasn't that really an "arbitrary" date that CVM set, several months ago? (because they "needed to fill-in the blanks, on the FDA update forms"?) Paraphrasing here, but I swear I recall someone posted that was essentially what Gavin said, regarding that.


I guess I am just hoping a lot of new investors (or even seasoned ones), won't be disappointed when/if October arrives, and there's neither 298 "events" yet, nor any IDMC recommendations.


Not being negative, only trying to separate fact from assumption! (I am long, and have been in this stock for over 10 years).

As far as I am concerned, more time means more effectiveness!

Just my two cents. :)